Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NADK | O95544 | 2/20 | 0.59 |
| ▸ | HSPA5 | P11021 | 2/20 | 0.58 |
| ▸ | HSPA8 | P11142 | 2/20 | 0.58 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | GAPDH | P04406 | 1/20 | 0.52 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30237237 | 0.92 | NADK (0.61) | NADKHSPA5HSPA8RXFP1HSD17B10 | |
| SCHEMBL5672193 | 0.92 | NADK (0.61) | NADKHSPA5HSPA8RXFP1HSD17B10 | |
| SCHEMBL1740341 | 0.92 | NADK (0.61) | NADKHSPA5HSPA8RXFP1HSD17B10 | |
| SCHEMBL28823544 | 0.86 | NADK (0.78) | NADKHSPA5HSPA8RXFP1HSD17B10 | |
| SCHEMBL12030991 | 0.85 | NADK (0.79) | NADKHSPA5HSPA8RXFP1HSD17B10 | |
| SCHEMBL13587343 | 0.85 | NADK (0.79) | NADKHSPA5HSPA8RXFP1HSD17B10 | |
| SCHEMBL1106674 | 0.85 | NADK (0.79) | NADKHSPA5HSPA8RXFP1HSD17B10 | |
| SCHEMBL440926 | 0.85 | NADK (0.79) | NADKHSPA5HSPA8RXFP1HSD17B10 | |
| SCHEMBL6671819 | 0.85 | NADK (0.79) | NADKHSPA5HSPA8RXFP1HSD17B10 | |
| SCHEMBL440925 | 0.85 | NADK (0.79) | NADKHSPA5HSPA8RXFP1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112209930-A | Istradefylline derivative and preparation method and application thereof | 山东新华制药股份有限公司 | 2021-01-12 | — | — | CN | disclosed |